What's new

Presentation - Optimizing the dosage of human prescription drugs and biological products for the treatment of oncologic diseases: FDA guidance (Mirat Shah)

Presentation - Optimizing the dosage of human prescription drugs and biological products for the treatment of oncologic diseases: FDA guidance (Mirat Shah)

Mar 11, 2025 - 11:19
 0
Presentation - Optimizing the dosage of human prescription drugs and biological products for the treatment of oncologic diseases: FDA guidance (Mirat Shah)
Read More

Tags:

Previous Article

Cancer Medicines Forum: December 2024, Online, European Medicines Agency, Amster...

Next Article

Minutes of the Cancer Medicines Forum - December 2024

Related Posts

Data Analysis and Real World Interrogation Network (DARWIN EU)

Data Analysis and Real World Interrogation Network (DAR...

Feb 20, 2025  0

EudraVigilance training and support

EudraVigilance training and support

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Nimenrix, meningococcal groups A, C, W-135 and Y conjugate vaccine, Date of authorisation: 20/04/2012, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0